Vaxart, Inc. (VXRT)
0.4344
0.00 (0.00%)
USD |
OTCM |
Oct 09, 16:00
Vaxart Profit Margin (Quarterly) : -49.64% for June 30, 2026
Profit Margin (Quarterly) Chart
Historical Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -49.64% |
| March 31, 2026 | 13.20% |
| December 31, 2025 | 52.81% |
| September 30, 2025 | -11.24% |
| June 30, 2025 | -37.72% |
| March 31, 2025 | -74.68% |
| December 31, 2024 | -78.93% |
| September 30, 2024 | -285.4% |
| June 30, 2024 | -257.2% |
| March 31, 2024 | -1.12K% |
| December 31, 2023 | -535.4% |
| September 30, 2023 | -828.2% |
| June 30, 2023 | -1.66K% |
| March 31, 2023 | -3.72K% |
| December 31, 2022 | -108.7K% |
| September 30, 2022 | |
| June 30, 2022 | |
| March 31, 2022 | -29.53K% |
| December 31, 2021 | -28.06K% |
| September 30, 2021 | -8.79K% |
| June 30, 2021 | -14.39K% |
| March 31, 2021 | -3.16K% |
| December 31, 2020 | -3.89K% |
| September 30, 2020 | -3.05K% |
| June 30, 2020 | -1.72K% |
| Date | Value |
|---|---|
| March 31, 2020 | -44.69% |
| December 31, 2019 | -163.7% |
| September 30, 2019 | -1.16K% |
| June 30, 2019 | -6.63K% |
| March 31, 2019 | -24.76% |
| December 31, 2018 | -277.4% |
| September 30, 2018 | -2.33K% |
| June 30, 2018 | -1.46K% |
| March 31, 2018 | |
| June 30, 2017 | -5.90K% |
| March 31, 2017 | -89.80% |
| December 31, 2016 | -239.5% |
| September 30, 2016 | -10.00K% |
| June 30, 2016 | -1.17K% |
| March 31, 2016 | -98.11% |
| December 31, 2015 | -382.4% |
| September 30, 2015 | -388.2% |
| June 30, 2015 | -485.4% |
| March 31, 2015 | 20.34% |
| December 31, 2014 | 46.76% |
| September 30, 2014 | -985.7% |
| June 30, 2014 | -121.4% |
| March 31, 2014 | 10.85% |
| December 31, 2013 | -0.54% |
| September 30, 2013 | -31.71% |
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Profit Margin (Quarterly) Benchmarks
| Agenus, Inc. | -1.64% |
| Amgen, Inc. | 23.59% |
| Anika Therapeutics, Inc. | 10.15% |
| BioCryst Pharmaceuticals, Inc. | 35.92% |
| Imunon, Inc. | -- |
Profit Margin (Quarterly) Related Metrics
| Return on Equity | 59.57% |
| Return on Assets | 21.23% |
| Return on Invested Capital | 48.27% |
| Gross Profit Margin (Quarterly) | 97.27% |
| Operating Margin (Quarterly) | -48.45% |
| Return on Net Operating Assets | 42.03% |